|
PARD6B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.002800E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.963200E-01 |
| Normal-vs-Stage2 |
3.614800E-01 |
| Normal-vs-Stage3 |
4.366600E-01 |
| Normal-vs-Stage4 |
2.269600E-01 |
| Stage1-vs-Stage2 |
3.475000E-01 |
| Stage1-vs-Stage3 |
4.551200E-01 |
| Stage1-vs-Stage4 |
6.422200E-02 |
| Stage2-vs-Stage3 |
7.070000E-01 |
| Stage2-vs-Stage4 |
6.493200E-01 |
| Stage3-vs-Stage4 |
3.273800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.547800E-01 |
| Normal-vs-AfricanAmerican |
9.182400E-01 |
| Normal-vs-Asian |
7.452600E-01 |
| Caucasian-vs-AfricanAmerican |
6.235600E-01 |
| Caucasian-vs-Asian |
5.963800E-01 |
| AfricanAmerican-vs-Asian |
8.336200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.183000E-01 |
| Normal-vs-Female |
4.990600E-01 |
| Male-vs-Female |
9.544800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.644400E-01 |
| Normal-vs-Age(41-60Yrs) |
4.948200E-01 |
| Normal-vs-Age(61-80Yrs) |
2.708400E-01 |
| Normal-vs-Age(81-100Yrs) |
7.062000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.524200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.991500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.768200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.467600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.350000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.209800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.998700E-03 |
| Classical-VS-Follicular |
2.12090012219335E-10 |
| Classical-VS-Other |
9.935200E-01 |
| Classical-VS-Normal |
9.482800E-01 |
| Tall-VS-Follicular |
6.728300E-02 |
| Tall-VS-Other |
1.883180E-01 |
| Tall-VS-Normal |
2.407800E-01 |
| Follicular-VS-Other |
2.590200E-02 |
| Follicular-VS-Normal |
3.667700E-02 |
| Other-VS-Normal |
9.675000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.954000E-01 |
| Normal-vs-N1 |
4.046200E-01 |
| N0-vs-N1 |
7.105600E-01 |
|
|
